United Therapeutics

Pulmonary arterial hypertension (PAH) is a rare and progressive disease. United Therapeutics has a robust portfolio of best-in-class therapies that utilize the active molecule, treprostinil. This suite of treprostinil treatments gives patients the ability to meaningfully engage in life.

Categories - Campaign concept & visualization

breathe-2 copy.png
breathe-3 copy.png

We collaborated with a Japanese artist to create a refreshing mix of photography and illustration to demonstrate how patient's quality of life can be improved with Trepostinil.